EI-001 — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-12-31 in 3mo
ESTIMATED |
READOUT
Phase 2 Study to Evaluate EI-001 in Non-segmental Vitiligo Patients
Phase 2 · Non-segmental Vitiligo |
Elixiron Immunotherapeutics (Hong | EI-001 |
ClinicalTrials.gov ↗
✓ Source-checked 2026-09-20
Sponsor-projected date — can change
|